The ExAblate Neuro device has been approved by the U.S. Food and Drug Administration to deliver focused ultrasound to destroy small bits of brain tissue that are thought to be involved in a neurological condition known as essential tremor.
The device, approved for people who haven’t responded to medication or surgery, uses MRI scans to help doctors focus ultrasound on specific areas of the brain, the FDA explained Monday in a news release. Patients are awake and responsive during the entire procedure, the agency added.
